Search research articles
Contact Us
Filters
Showing results (141-150 of 247) with videos related to
Page
of 25
Sort By:
Cancer
|
October 21, 2023
Phase 1/2 trial of avelumab combined with utomilumab (4-1BB agonist), PF-04518600 (OX40 agonist), or radiotherapy in patients with advanced gynecologic malignancies
Anne Knisely, Jibran Ahmed, Bettzy Stephen, et al.
Nature Communications
|
January 9, 2026
Two-year persistence of MERS-CoV-specific antibody and T cell responses after MVA-MERS-S vaccination in healthy adults
Leonie Mayer, Anahita Fathi, Hanna-Marie Weichel, et al.
Molecular Oncology
|
June 16, 2017
Analysis of mutant allele fractions in driver genes in colorectal cancer - biological and clinical insights
Rodrigo Dienstmann, Elena Elez, Guillem Argiles, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 27, 2014
First-in-human dose study of the novel transforming growth factor-β receptor I kinase inhibitor LY2157299 monohydrate in patients with advanced cancer and glioma
Jordi Rodon, Michael A Carducci, Juan M Sepulveda-Sánchez, et al.
Journal for Immunotherapy of Cancer
|
August 21, 2023
T-cell receptor beta variable gene polymorphism predicts immune-related adverse events during checkpoint blockade immunotherapy
Bettzy Stephen, Joud Hajjar, Shrutii Sarda, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 17, 2018
First-in human, phase 1, dose-escalation pharmacokinetic and pharmacodynamic study of the oral dual PI3K and mTORC1/2 inhibitor PQR309 in patients with advanced solid tumors (SAKK 67/13)
Andreas Wicki, Nicholas Brown, Alexandros Xyrafas, et al.
Neuro-Oncology
|
February 24, 2016
A Phase II randomized study of galunisertib monotherapy or galunisertib plus lomustine compared with lomustine monotherapy in patients with recurrent glioblastoma
Alba A Brandes, Antoine F Carpentier, Santosh Kesari, et al.
Journal of Immunotherapy and Precision Oncology
|
February 8, 2024
Limited Independent Follow-Up with Germline Testing of Variants Detected in <i>BRCA1</i> and <i>BRCA2</i> by Tumor-Only Sequencing
Carol J Nowlen, Molly Daniels, Burak Uzunparmak, et al.
Journal for Immunotherapy of Cancer
|
February 16, 2021
Integrating genome-wide CRISPR immune screen with multi-omic clinical data reveals distinct classes of tumor intrinsic immune regulators
Jiakai Hou, Yunfei Wang, Leilei Shi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 9, 2018
Precision Oncology Decision Support: Current Approaches and Strategies for the Future
Katherine C Kurnit, Ecaterina E Ileana Dumbrava, Beate Litzenburger, et al.
Page
of 25
Search research articles
Search
Showing results (141-150 of 247) with videos related to
Sort By:
Page
of 25
Cancer
|
October 21, 2023
Phase 1/2 trial of avelumab combined with utomilumab (4-1BB agonist), PF-04518600 (OX40 agonist), or radiotherapy in patients with advanced gynecologic malignancies
Anne Knisely, Jibran Ahmed, Bettzy Stephen, et al.
Nature Communications
|
January 9, 2026
Two-year persistence of MERS-CoV-specific antibody and T cell responses after MVA-MERS-S vaccination in healthy adults
Leonie Mayer, Anahita Fathi, Hanna-Marie Weichel, et al.
Molecular Oncology
|
June 16, 2017
Analysis of mutant allele fractions in driver genes in colorectal cancer - biological and clinical insights
Rodrigo Dienstmann, Elena Elez, Guillem Argiles, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 27, 2014
First-in-human dose study of the novel transforming growth factor-β receptor I kinase inhibitor LY2157299 monohydrate in patients with advanced cancer and glioma
Jordi Rodon, Michael A Carducci, Juan M Sepulveda-Sánchez, et al.
Journal for Immunotherapy of Cancer
|
August 21, 2023
T-cell receptor beta variable gene polymorphism predicts immune-related adverse events during checkpoint blockade immunotherapy
Bettzy Stephen, Joud Hajjar, Shrutii Sarda, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 17, 2018
First-in human, phase 1, dose-escalation pharmacokinetic and pharmacodynamic study of the oral dual PI3K and mTORC1/2 inhibitor PQR309 in patients with advanced solid tumors (SAKK 67/13)
Andreas Wicki, Nicholas Brown, Alexandros Xyrafas, et al.
Neuro-Oncology
|
February 24, 2016
A Phase II randomized study of galunisertib monotherapy or galunisertib plus lomustine compared with lomustine monotherapy in patients with recurrent glioblastoma
Alba A Brandes, Antoine F Carpentier, Santosh Kesari, et al.
Journal of Immunotherapy and Precision Oncology
|
February 8, 2024
Limited Independent Follow-Up with Germline Testing of Variants Detected in <i>BRCA1</i> and <i>BRCA2</i> by Tumor-Only Sequencing
Carol J Nowlen, Molly Daniels, Burak Uzunparmak, et al.
Journal for Immunotherapy of Cancer
|
February 16, 2021
Integrating genome-wide CRISPR immune screen with multi-omic clinical data reveals distinct classes of tumor intrinsic immune regulators
Jiakai Hou, Yunfei Wang, Leilei Shi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 9, 2018
Precision Oncology Decision Support: Current Approaches and Strategies for the Future
Katherine C Kurnit, Ecaterina E Ileana Dumbrava, Beate Litzenburger, et al.
Page
of 25